about
Drug delivery and nanoparticles:applications and hazardsAdvances and Challenges of Liposome Assisted Drug DeliveryFabrication principles and their contribution to the superior in vivo therapeutic efficacy of nano-liposomes remote loaded with glucocorticoidsPEG minocycline-liposomes ameliorate CNS autoimmune disease.Improving In Vivo Efficacy of Bioactive Molecules: An Overview of Potentially Antitumor Phytochemicals and Currently Available Lipid-Based Delivery Systems.Multimodal clinical imaging to longitudinally assess a nanomedical anti-inflammatory treatment in experimental atherosclerosis.Imaging the efficacy of anti-inflammatory liposomes in a rabbit model of atherosclerosis by non-invasive imaging.Role of in vitro release models in formulation development and quality control of parenteral depots.Using liposomes to target infection and inflammation induced by foreign body injuries or medical implants.Overcoming in vivo barriers to targeted nanodelivery.Targeting sites of inflammation: intercellular adhesion molecule-1 as a target for novel inflammatory therapies.The use of lipid-based nanocarriers for targeted pain therapies.Advances in lipid-based drug delivery: enhancing efficiency for hydrophobic drugs.Strategies to target drugs to gliomas and CNS metastases of solid tumors.Tumor Necrosis Factor-Alpha Up-Regulates ICAM-1 Expression and Release in Intestinal Myofibroblasts by Redox-Dependent and -Independent Mechanisms.Radionuclide imaging of liposomal drug delivery.Liposomal encapsulation of a near-infrared fluorophore enhances fluorescence quenching and reliable whole body optical imaging upon activation in vivo.Liposomal formulation of chondroitin sulfate enhances its antioxidant and anti-inflammatory potential in L929 fibroblast cell line.P-Selectin Targeted Dexamethasone-Loaded Lipid Nanoemulsions: A Novel Therapy to Reduce Vascular Inflammation.Adaptability and elasticity of the mixed lipid bilayer vesicles containing non-ionic surfactant designed for targeted drug delivery across the skin.Folate-conjugated liposomes target and deliver therapeutics to immune cells in a rat model of rheumatoid arthritis.Effects of Micro-environmental pH of Liposome on Chemical Stability of Loaded Drug.Advantages and Limitations of Current Imaging Techniques for Characterizing Liposome Morphology.Contrast enhancement by lipid-based MRI contrast agents in mouse atherosclerotic plaques; a longitudinal studyThe right touch: design of artificial antigen-presenting cells to stimulate the immune systemPreparation and Characterization of a Collagen-Liposome-Chondroitin Sulfate Matrix with Potential Application for Inflammatory Disorders Treatment
P2860
Q24655744-AE183789-58CD-4015-8669-9020D626AEC7Q26773160-C41EA10A-2C0B-43ED-9D63-495E0804F38AQ28477392-854C7915-E6B3-4CAB-9D75-444F5124F4F8Q33398048-4DF4F992-EB76-4071-BFEF-D991354C9782Q33710442-F06BF5B1-F1D0-4C85-B315-C60FC20528C8Q35936550-AA6673C0-F0E9-44B7-99F1-16DDE2D8FEDDQ36728733-BC9DD85D-1B91-4353-80EC-A030EDFE9FD7Q37639309-F96ADD8B-6993-44B4-BEA7-6D998EA6C116Q37790712-7571CDFC-91B5-4280-8EC6-B5EC13C3F043Q37871580-B658DCBE-7EB3-493F-981C-72F4C685213CQ38151092-49F578C3-AD4F-46E9-8F1E-553D102CEB2BQ38169707-5C631331-4DF4-4B74-BB3C-326F28A4B8A7Q38406190-B5F6F9E5-B6AE-4605-875D-F09676A6BD3EQ38610113-C4E5CB7B-AF2C-46A4-9229-AF65ED78B182Q38852709-EEFC11CE-9A8F-4AFB-BC71-3BDCB873A137Q38879338-AE16845D-69A3-445C-ABD4-6CAB18E6BE67Q39155321-21A03DEB-C2C0-404F-8F24-9EFA96E695C4Q39165523-5176B524-9FD9-465D-B6A1-22BD62817A21Q41200749-B074E8C4-963A-4AFC-930D-A1EEDD95EC01Q45231396-5421059B-B0D0-466B-949A-2626210461E4Q47607208-C9EF587F-420E-4530-801A-62F65EE758C2Q48184284-3F564A08-F74C-40A7-9625-7891485A891BQ50275432-DE7123DB-9D10-4D92-8B9B-6FD35758F01DQ57183923-A43E928E-36DC-4762-B7D7-79FF28B3E48CQ58619853-588B4421-0409-447F-974D-973869A84CE5Q59059461-54C39EED-638B-4A8B-97EF-04849D224A3C
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Liposomes in the treatment of inflammatory disorders.
@ast
Liposomes in the treatment of inflammatory disorders.
@en
type
label
Liposomes in the treatment of inflammatory disorders.
@ast
Liposomes in the treatment of inflammatory disorders.
@en
prefLabel
Liposomes in the treatment of inflammatory disorders.
@ast
Liposomes in the treatment of inflammatory disorders.
@en
P2860
P356
P1476
Liposomes in the treatment of inflammatory disorders.
@en
P2093
Gert Storm
Josbert M Metselaar
P2860
P304
P356
10.1517/17425247.2.3.465
P407
P577
2005-05-01T00:00:00Z